Stocks and Investing Stocks and Investing
Thu, February 20, 2020

John Ransom Maintained (AMED) at Buy with Increased Target to $225 on, Feb 20th, 2020


Published on 2024-10-26 22:18:45 - WOPRAI, John Ransom
  Print publication without navigation


John Ransom of Raymond James, Maintained "Amedisys, Inc." (AMED) at Buy with Increased Target from $200 to $225 on, Feb 20th, 2020.

John has made no other calls on AMED in the last 4 months.



There are 6 other peers that have a rating on AMED. Out of the 6 peers that are also analyzing AMED, 3 agree with John's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Matt Borsch of "BMO Capital" Initiated at Hold and Held Target at $170 on, Friday, December 6th, 2019
  • Andrew Mok of "UBS" Maintained at Hold with Increased Target to $154 on, Thursday, November 7th, 2019
  • Scott Fidel of "Stephens & Co." Initiated at Hold and Held Target at $145 on, Tuesday, October 22nd, 2019


These are the ratings of the 3 analyists that currently disagree with John


  • A.J. Rice of "Credit Suisse" Initiated at Buy and Held Target at $206 on, Friday, January 17th, 2020
  • Joanna Gajuk of "B of A Securities" Maintained at Strong Buy with Increased Target to $178 on, Tuesday, November 26th, 2019
  • Whit Mayo of "Baird" Upgraded from Hold to Buy on, Friday, November 1st, 2019
Contributing Sources